Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
[[Image:|151px|Benzphetamine chemical structure]] | |
| N-benzyl-N-methyl-1-phenyl-propan-2-amine IUPAC name | |
| CAS number 156-08-1 |
ATC code [[ATC_code_|]][1] |
| PubChem 2341 |
DrugBank APRD00759 |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 239.355 g/mol |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | {{{excretion}}} |
| Pregnancy category | |
| Legal status | CIII |
| Routes of administration | |
Benzphetamine (brand name: Didrex) is an anti-obesity drug marketed under this brand in the USA by Pharmacia. Benzphetamine is used as a short term adjunct in management of exogenous obesity. It is closely related to amphetamine.
Benzphetamine is unique in its classification as a Schedule III drug in the United States. (Most members of the amphetamine family are classified in the more highly-regulated Schedule II.) It's notable that benzphetamine is metabolized by the human body into amphetamine and methamphetamine metabolites, making it one of the very few drugs to undergo in vivo conversion to a substance of higher addiction and abuse potential.
| Amphetamines edit |
|---|
|
4-FMP Amphetamine Benzphetamine Dextroamphetamine dl-Amphetamine MDMA MDA MDEA Methamphetamine Paramethoxyamphetamine |
- es:Benzfetamina
- pl:Benzfetamina
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |